China’s MGI Tech said it would press ahead with the US rollout of its gene sequencing machines as it was “completely different” from its former parent group, which has been blacklisted in the US.
Shenzhen-based MGI was a subsidiary of BGI — parts of which are subject to US trade restrictions over concerns about the security of Americans’ genetic data — before it was spun out and listed on the Shanghai stock exchange in 2022.
BGI founder Wang Jian still holds 47 per cent of MGI shares, according to business data platform Tianyancha.
您已閱讀10%（535字），剩余90%（4672字）包含更多重要信息，訂閱以繼續探索完整內容，并享受更多專屬服務。